Forward Citations = 13

Loading Chart...

7 inventors (with patents filed for the assignee):

Juergen K Naggert (4 out of 6 patents)

Patsy M Nishina (4 out of 6 patents)

Michael North (4 out of 6 patents)

4. Konrad Noben-Trauth (2 out of 3 patents)

5. Alisa Goldstein (1 out of 1 patent)

6. Margaret Tucker (1 out of 1 patent)

7. Nicolas Dracopoli (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 5776762 - Obesity associated genes (1998-07-07),

2. 5770432 - Obesity associated genes (1998-06-23),

3. 5714329 - Methods for the diagnosis of a genetic predisposition to cancer (1998-02-03),

4. 5705380 - Identification of a gene encoding TULP2, a retina specific protein (1998-01-06),

5. 5686598 - Genes associated with retinal dystrophies (1997-11-11),

Company Overview

Sequana Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for patients with serious diseases. The company leverages advanced genomic technologies to discover and develop novel therapeutics aimed at addressing unmet medical needs. With a commitment to precision medicine, Sequana Therapeutics aims to transform the treatment landscape for various conditions by harnessing the power of genetic insights and cutting-edge research. Their pipeline includes programs targeting rare genetic disorders and other challenging diseases, with a focus on improving patient outcomes through tailored therapeutic approaches.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#66 in La Jolla, CA

#12,070 in California

#51,540 in US

La Jolla, CA, United States of America

Sequana Therapeutics, Inc.

Forward Citations = 13

7 inventors:

Juergen K Naggert (4 out of 6 patents)

Patsy M Nishina (4 out of 6 patents)

Michael North (4 out of 6 patents)

4. Konrad Noben-Trauth (2 out of 3 patents)

5. Alisa Goldstein (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sequana Therapeutics, Inc.. Retrieved from https://idiyas.com/company/sequana-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]